Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A11QVV0
Fri, 09.09.2022       Heidelberg Pharma AG
DE000A11QVV0

Ad hoc announcement - Insider information pursuant to Article 17 MAR Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate Ladenburg, Germany, 9 September 2022 – Heidelberg Pharma AG (FSE: HPHA) today announced that its subsidiary Heidelberg Pharma Research GmbH and Take [ … ]
Technical analysis
To the publication
Fri, 09.09.2022       Heidelberg Pharma AG
DE000A11QVV0

Ad hoc announcement - Insider information pursuant to Article 17 MAR Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate Ladenburg, Germany, 9 September 2022 – Heidelberg Pharma AG (FSE: HPHA) today announced that its subsidiary Heidelberg Pharma Research GmbH and Take [ … ]
Technical analysis
To the publication
Tue, 30.08.2022       Heidelberg Pharma AG
DE000A11QVV0

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. PRESS RELEASE Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure All allowable shares  [ … ]
Technical analysis
To the publication
Tue, 30.08.2022       Heidelberg Pharma AG
DE000A11QVV0

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. PRESS RELEASE Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure All allowable shares  [ … ]
Technical analysis
To the publication
Fri, 12.08.2022       Heidelberg Pharma AG
DE000A11QVV0

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. PRESS RELEASE Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million Ladenburg, Germany, 12 August 20 [ … ]
Technical analysis
To the publication
Fri, 12.08.2022       Heidelberg Pharma AG
DE000A11QVV0

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. PRESS RELEASE Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million Ladenburg, Germany, 12 August 20 [ … ]
Technical analysis
To the publication
Wed, 13.07.2022       Heidelberg Pharma AG
DE000A11QVV0

Ad hoc announcement - Inside information pursuant to Article 17 MAR Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate Ladenburg, Germany, 13 July 2022 – Heidelberg Pharma AG (FSE: HPHA) and Chiome Bioscience Inc., Tokyo, Japan, (Tokyo: 4583) toda [ … ]
Technical analysis
To the publication
Wed, 13.07.2022       Heidelberg Pharma AG
DE000A11QVV0

Ad hoc announcement - Inside information pursuant to Article 17 MAR Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate Ladenburg, Germany, 13 July 2022 – Heidelberg Pharma AG (FSE: HPHA) and Chiome Bioscience Inc., Tokyo, Japan, (Tokyo: 4583) toda [ … ]
Technical analysis
To the publication
Tue, 12.07.2022       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma Reports on First Half-Year 2022 First clinical trial with HDP-101 in multiple myeloma on track, third cohort in preparation Signing of a strategic partnership with Huadong Medicine with an overall deal volume of up to one billion US dollars and an investment agreement of up to EUR 105 million; rights issue of up  [ … ]
Technical analysis
To the publication
Tue, 12.07.2022       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma Reports on First Half-Year 2022 First clinical trial with HDP-101 in multiple myeloma on track, third cohort in preparation Signing of a strategic partnership with Huadong Medicine with an overall deal volume of up to one billion US dollars and an investment agreement of up to EUR 105 million; rights issue of up  [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 04.07.2024, Calendar Week 27, 186th day of the year, 180 days remaining until EoY.